Therapy News and Research

RSS

Genetic therapy may help children with Angelman syndrome to overcome seizures

Angelman syndrome is a genetic disease with no cure. Children grow up with severe intellectual disabilities and a range of other problems, arguably the worst of which are epileptic seizures. Now scientists at the UNC School of Medicine have found evidence that genetic therapy may prevent the enhanced seizure susceptibility.

21 Nov 2018

Myriad biological, societal factors that impact CKD severity for children of African descent

Myriad biological and societal factors can impact the occurrence and accelerate progression of chronic kidney disease for children of African descent - including preterm birth, exposure to toxins during gestation and lower socioeconomic status - and can complicate these children's access to effective treatments, according to an invited commentary published in the November 2018 edition of American Journal of Kidney Diseases.

21 Nov 2018

Groundbreaking research projects show how AI can be used to predict under diagnosed chronic diseases

Zebra Medical Vision and Clalit Health Services announce the completion of two groundbreaking research projects that allow early identification of patients with bone and cardiovascular disease.

21 Nov 2018

Survey: Misconceptions about opioid use undermine pain control among Asian cancer patients

Misconceptions about the use of strong opioids showed to undermine optimal pain control among Asian cancer patients undergoing chemotherapy and radiotherapy according to a cross-sectional survey conducted at the Sarawak General Hospital in Malaysia.

21 Nov 2018

Potential new therapeutic approach developed for synovial sarcoma

Scientists have developed a potential new therapeutic approach for synovial sarcoma, one of the most common soft-tissue cancers in teenagers and young adults.

20 Nov 2018

DNA vaccine reduces levels of toxic proteins in Alzheimer’s model

Researchers have developed a new DNA vaccine that reduces the build-up of the toxic proteins associated with Alzheimer’s disease.

20 Nov 2018

Blocking activity of plasma protein can be possible way to protect against radiation-induced injury

It is possible to prevent certain injuries that can occur in radiation therapy against cancer. By blocking the activity of a plasma protein during and immediately after radiation, the patient can be protected against injury. This is shown in a new doctoral thesis at Umeå University, Sweden.

20 Nov 2018

Survey: Pulmonologists want more information on inhalation devices for COPD

In an era of personalized medicine, physicians treating patients with chronic obstructive pulmonary disease should consider individualized therapy depending on disease severity and the cost and availability of medications.

20 Nov 2018

Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration

In January 2009, the life of engineer Michel Meunier, a professor at Polytechnique Montréal, changed dramatically. Like others, he had observed that the extremely short pulse of a femtosecond laser (0.000000000000001 second) could make nanometer-sized holes appear in silicon when it was covered by gold nanoparticles.

20 Nov 2018

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

The Abramson Cancer Center (ACC) at the University of Pennsylvania announced today that it is joining the National Comprehensive Cancer Network (NCCN) as its 28th member institution.

20 Nov 2018

LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data

Interstitial brachytherapy uses slightly radioactive particles implanted into the prostate to deliver radiation directly to the tumour (low-dose-rate, LDR).

20 Nov 2018

Scientists identify novel target for neuron regeneration, functional recovery in spinal cord injury

Restoring the ability to walk following spinal cord injury requires neurons in the brain to reestablish communication pathways with neurons in the spinal cord.

20 Nov 2018

Study warns that potential epigenetic therapy may boost lung cancer stem cells

Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

20 Nov 2018

New research offers hope for simpler way to diagnose and treat cancer

Monitoring cancer can often be an intrusive and exhausting process for patients. But with Brigham Young University chemistry professor Ryan Kelly's new research, there is hope for a simpler way: No more biopsies.

20 Nov 2018

Cessation fatigue predicts relapse rate after attempts to quit smoking

Although there is good news about smoking -- only 14 percent of Americans smoke, the lowest number ever, according to a 2017 National Health Interview Survey -- challenges remain. In a given year, more than 40 percent of smokers make no attempt to quit.

20 Nov 2018

Replacement of dysfunctional microglia has therapeutic potential for neurodegenerative diseases

A new study by researchers at Karolinska Institutet supports the theory that replacement of dysfunctional immune cells in the brain has therapeutic potential for neurodegenerative diseases like ALS and Alzheimer's disease.

19 Nov 2018

RNAi therapy shown to alleviate preeclampsia in animal model

Researcher have used a small interfering RNA (siRNA) to reduce preeclampsia symptoms in an animal model. The approach could provide a new way of treating preeclampsia in humans.

19 Nov 2018

Participation project calls for relaxing research ban on germline interventions

Are genetic defects allowed to be repaired by intervening with sperm or egg cells, or even human embryos? Thanks to genetic scissors such as CRISPR/Cas, such interventions in the germline could soon become a medical reality.

19 Nov 2018

New solution to stop spread of brain cancer

The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

19 Nov 2018

Researchers identify molecule to fight myotubular myopathy

Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva, Switzerland, - working in collaboration with the University of Strasbourg, France, - have identified a molecule that not only greatly reduces the progression of the disease but also boosts life expectancy in animal models by a factor of seven.

19 Nov 2018

Therapy News and Research

Genetic therapy may help children with Angelman syndrome to overcome seizures

Myriad biological, societal factors that impact CKD severity for children of African descent

Groundbreaking research projects show how AI can be used to predict under diagnosed chronic diseases

Survey: Misconceptions about opioid use undermine pain control among Asian cancer patients

Potential new therapeutic approach developed for synovial sarcoma

DNA vaccine reduces levels of toxic proteins in Alzheimer’s model

Blocking activity of plasma protein can be possible way to protect against radiation-induced injury

Survey: Pulmonologists want more information on inhalation devices for COPD

Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data

Scientists identify novel target for neuron regeneration, functional recovery in spinal cord injury

Study warns that potential epigenetic therapy may boost lung cancer stem cells

New research offers hope for simpler way to diagnose and treat cancer

Cessation fatigue predicts relapse rate after attempts to quit smoking

Replacement of dysfunctional microglia has therapeutic potential for neurodegenerative diseases

RNAi therapy shown to alleviate preeclampsia in animal model

Participation project calls for relaxing research ban on germline interventions

New solution to stop spread of brain cancer

Researchers identify molecule to fight myotubular myopathy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News